Loading clinical trials...
Loading clinical trials...
The purpose of this study is to collect data for assessing the improvement of the overall response rate for the overall cohorts and the proportion of patients accessing precision targeted therapy.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University Health Network, Toronto
NCT07527624 · Rare Diseases
NCT05735080 · Breast Cancer, Breast Cancer Metastatic, and more
NCT06595940 · Undiagnosed Diseases, Rare Diseases
NCT04657068 · Advanced Cancer, Metastatic Cancer, and more
NCT07247279 · Rare Diseases, Generalized Myasthenia Gravis (gMG)
University Health Network, Princess Margaret Cancer Centre
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions